News

Certriad is an investigational compound under joint development by AstraZeneca and Abbott for the treatment of mixed dyslipidemia. Abbott and AstraZeneca’s decision was made after careful consideration of

The funds will be designated and used by Oramed Ltd to support further R&D and clinical study of its Oral Insulin capsule and Oral GLP1-Analog. Oramed Pharmaceuticals CEO

In its CRL, the agency confirmed that patients with Coma Grade I/II observed a numerically higher rate of transplant-free survival, but also noted that there was not sufficient

Elacytarabine is a novel, patented lipid-conjugated (LVT) form of the anti-cancer drug cytarabine (Ara-C) for the treatment patients with AML and other haematological malignancies (leukaemias), which has the

ISIS-APOCIIIRx works by inhibiting the production of apolipoprotein C-III (apoC-III), a traditionally ‘undruggable’ target that plays an important role in the regulation of triglycerides. Isis Cardiovascular Diseases Drug

The FlexStent Biliary Self Expanding Stent System is indicated for the palliative treatment of biliary strictures resulting from malignant neoplasms. The expansion of the FlexStent Biliary Stent size

Naprod Life Sciences and Pharmasyntez will sign a memorandum of understanding for setting up a manufacturing unit in Saint Petersburg, Russia, with technology transfer by Naprod. Apart from

The French regulatory authority (AFSSAPS) has authorized manufacturing operations including the production of biotechnology products, immunology products and extracted products from animal or human origin. The new facility

Under the agreement, PS Biomarker Services is expected to use a combination of its proprietary TMT isobaric mass tag technology, sample preparation and bioinformatics with Orbitrap Velos mass